An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study

Show other versions (2)

OBJECTIVE: To independently evaluate the performance of the QRISK score for predicting 10 year risk of cardiovascular disease in an independent UK cohort of patients from general practice and compare the performance with Framingham equations. DESIGN: Prospective open cohort study. SETTING: 274 pract...

Full description

Bibliographic Details
Main Authors:	Collins, G, Altman, D
Format:	Journal article
Published:	2009

Similar Items

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.
by: Collins, G, et al.
Published: (2009)

An independent external validation and evaluation of QRISK cardiovascular risk prediction: A prospective open cohort study
by: Collins, G, et al.
Published: (2009)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study
by: Collins, G, et al.
Published: (2010)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.
by: Collins, G, et al.
Published: (2010)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.
by: Collins, G, et al.
Published: (2010)

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
by: Collins, G, et al.
Published: (2012)

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
by: Collins, G, et al.
Published: (2012)

QRISK validation and evaluation Authors' reply
by: Collins, G, et al.
Published: (2009)

Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank
by: Parsons, RE, et al.
Published: (2023)

QRISK validation and evaluation: QRISK may be less useful
by: Su, M, et al.
Published: (2009)

QRISK validation and evaluation. QRISK may be less useful.
by: Liew, S, et al.
Published: (2009)

QRISK2-2011 predicted cardiovascular disease in adult general practice patients
by: Collins, G, et al.
Published: (2012)

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
by: Hippisley-Cox, J, et al.
Published: (2017)

Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study
by: Shona Livingstone, MSc, et al.
Published: (2021-06-01)

UPDATED VERSION OF QRISK2 Authors' reply to Bird
by: Collins, G, et al.
Published: (2012)

Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
by: Manpreet Singh, et al.
Published: (2022-07-01)

Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores.
by: Collins, G, et al.
Published: (2011)

Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores.
by: Collins, G, et al.
Published: (2011)

Predicting the adverse risk of statin treatment: An independent and external validation of Qstatin risk scores in the UK
by: Collins, G, et al.
Published: (2012)

Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UK.
by: Collins, G, et al.
Published: (2012)

QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease
by: Marta Carrillo-Palau, et al.
Published: (2021-09-01)

Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study
by: Shona J. Livingstone, et al.
Published: (2022-05-01)

Identifying women with undetected ovarian cancer: independent and external validation of QCancer(®) (Ovarian) prediction model.
by: Collins, G, et al.
Published: (2013)

Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk?
by: Tjeerd-Pieter van Staa, et al.
Published: (2014-01-01)

Identifying patients with undetected renal tract cancer in primary care: an independent and external validation of QCancer® (Renal) prediction model.
by: Collins, G, et al.
Published: (2013)

External validation of the QLifetime cardiovascular risk prediction tool: population cohort study
by: Shona Livingstone, et al.
Published: (2023-04-01)

External validation of QDSCORE(®) for predicting the 10-year risk of developing Type 2 diabetes.
by: Collins, G, et al.
Published: (2011)

Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer(®) (Pancreas).
by: Collins, G, et al.
Published: (2013)

Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus
by: Xiaodie Mu, et al.
Published: (2022-11-01)

Cardiovascular risk stratification in new-onset diabetes by qrisk2 risk score and conventional risk score within 3 months of diagnosis of diabetes
by: Sujata Hiran, et al.
Published: (2018-01-01)

Predictors for independent external validation of cardiovascular risk clinical prediction rules: Cox proportional hazards regression analyses
by: Ban, J, et al.
Published: (2018)

Predictors for independent external validation of cardiovascular risk clinical prediction rules: Cox proportional hazards regression analyses
by: Jong-Wook Ban, et al.
Published: (2018-02-01)

Cardiovascular disease risk communication in NHS Health Checks using QRISK®2 and JBS3 risk calculators: the RICO qualitative and quantitative study
by: Christopher J Gidlow, et al.
Published: (2021-08-01)

Clinical prediction models in epidemiological studies: lessons from the application of QRISK3 to UK Biobank Data
by: Parsons, RE, et al.
Published: (2022)

Assessment of QRISK3 Score in Normoglycaemic, Prediabetic and Diabetic Subjects: An Observational Study
by: Aayushee Rao, et al.
Published: (2023-07-01)

External validation of the prediction model of intradialytic hypotension: a multicenter prospective cohort study
by: Yuhe Xiang, et al.
Published: (2024-12-01)

Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort
by: Jae Hyun Bae, et al.
Published: (2020-06-01)

Chronic renal disease is not chronic kidney disease: implications for use of the QRISK and Joint British Societies risk scores
by: Stevens, S, et al.
Published: (2015)

Predictive role of novel echocardiographic parameter aortic velocity propagation, QRISK3 and Framingham risk score for presence and severity of CAD in Asian patients
by: Pooja Vyas, et al.
Published: (2022-09-01)

The effect of long-acting injectable antipsychotics on QRISK3 in patients with bipolar disorder and schizophrenia
by: V. Erbasan, et al.
Published: (2023-03-01)